Investigating the antimicrobial peptide ‘window of activity’ using cationic lipopeptides with hydrocarbon and fluorinated tails

Arias, 2009, Antibiotic-resistant bugs in the 21st century—a clinical super-challenge, N Engl J Med, 360, 439, 10.1056/NEJMp0804651

Mulvey, 2009, Antimicrobial resistance in hospitals: how concerned should we be?, CMAJ, 180, 408, 10.1503/cmaj.080239

Hale, 2007, Alternative mechanisms of action of cationic antimicrobial peptides on bacteria, Expert Rev Anti Infect Ther, 5, 951, 10.1586/14787210.5.6.951

Ge, 1999, In vitro antibacterial properties of pexiganan, an analog of magainin, Antimicrob Agents Chemother, 43, 782, 10.1128/AAC.43.4.782

Perron, 2006, Experimental evolution of resistance to an antimicrobial peptide, Proc Biol Sci, 273, 251, 10.1098/rspb.2005.3301

Lipsky, 2008, Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream, Clin Infect Dis, 47, 1537, 10.1086/593185

Yeung, 2011, Multifunctional cationic host defence peptides and their clinical applications, Cell Mol Life Sci, 68, 2161, 10.1007/s00018-011-0710-x

Marr, 2006, Antibacterial peptides for therapeutic use: obstacles and realistic outlook, Curr Opin Pharmacol, 6, 468, 10.1016/j.coph.2006.04.006

Wang, 2012, Production, purification, and characterization of the cecropin from Plutella xylostella, pxCECA1, using an intein-induced self-cleavable system in Escherichia coli, Appl Microbiol Biotechnol, 10.1007/s00253-011-3863-5

Makovitzki, 2008, Antimicrobial lipopolypeptides composed of palmitoyl di- and tricationic peptides: in vitro and in vivo activities, self-assembly to nanostructures, and a plausible mode of action, Biochemistry, 47, 10630, 10.1021/bi8011675

Malina, 2005, Conjugation of fatty acids with different lengths modulates the antibacterial and antifungal activity of a cationic biologically inactive peptide, Biochem J, 390, 695, 10.1042/BJ20050520

Svenson, 2007, Albumin binding of short cationic antimicrobial micropeptides and its influence on the in vitro bactericidal effect, J Med Chem, 50, 3334, 10.1021/jm0703542

Meng, 2007, Antimicrobial activity and protease stability of peptides containing fluorinated amino acids, J Am Chem Soc, 129, 15615, 10.1021/ja075373f

Gottler, 2008, Using fluorous amino acids to modulate the biological activity of an antimicrobial peptide, Chembiochem, 9, 370, 10.1002/cbic.200700643

Chan, 2000

Clinical Laboratory Standards Institute. Protocols for evaluating dehydrated Mueller–Hinton agar; approved standard. 2nd ed. Document M6-A2. Wayne, PA: CLSI; 2006.

Zhanel, 2008, Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005–2006, Antimicrob Agents Chemother, 52, 1430, 10.1128/AAC.01538-07

Zhanel, 2011, Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007–2009 study, Diagn Microbiol Infect Dis, 69, 291, 10.1016/j.diagmicrobio.2010.10.025

Dathe, 1996, Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes, Biochemistry, 35, 12612, 10.1021/bi960835f

Serrano, 2009, Antibacterial activity of ultrashort cationic lipo-β-peptides, Antimicrob Agents Chemother, 53, 2215, 10.1128/AAC.01100-08

Findlay, 2010, Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold, Antimicrob Agents Chemother, 54, 4049, 10.1128/AAC.00530-10

Mowery, 2007, Mimicry of antimicrobial host-defense peptides by random copolymers, J Am Chem Soc, 129, 15474, 10.1021/ja077288d

Kleywegt, 1996, Phi/psi-chology: Ramachandran revisited, Structure, 4, 1395, 10.1016/S0969-2126(96)00147-5